Detalhe da pesquisa
1.
Outcome of older myeloma patients in relationship to comorbidities and availability of second-generation novel agents in a real-life setting.
Hematol Oncol
; 40(4): 716-723, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35574642
2.
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Blood
; 134(4): 353-362, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31101627
3.
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.
Br J Haematol
; 176(5): 770-782, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27983764
4.
Vemurafenib in combination with cobimetinib in relapsed and refractory extramedullary multiple myeloma harboring the BRAF V600E mutation.
Hematol Oncol
; 35(4): 890-893, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641727
5.
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab.
Blood
; 133(5): 494-497, 2019 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455380
6.
Salvage Chemotherapy with R-DHAP in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma.
Cancer Invest
; 34(8): 361-72, 2016 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27635469
7.
Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08).
Haematologica
; 101(3): 346-55, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26659919
8.
Improved survival of older patients with multiple myeloma in the era of novel agents.
Hematol Oncol
; 34(4): 217-223, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25898820
9.
[Current treatment strategies for multiple myeloma]. / Aktuelle Behandlungskonzepte in der Therapie des Multiplen Myeloms.
Ther Umsch
; 67(10): 527-35, 2010 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-20886459
10.
Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia.
Haematologica
; 92(12): 1699-702, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18055996
11.
DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis.
Leuk Lymphoma
; 47(12): 2558-66, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17169800
12.
High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma.
Ger Med Sci
; 5: Doc02, 2007 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-19675710
13.
Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma.
Support Care Cancer
; 15(7): 877-84, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17235504
14.
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Cancer Invest
; 24(6): 593-600, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16982464